Apidra SoloStar

$370.00 Sales Tax

Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and is sold under the trade

Apidra SoloStar

$370.00 Sales Tax

Add to cart
Buy Now
Description

Apidra SoloStar

  • Apidra SoloStar

    General information:

    Manufacturer: Sanofi Aventis
    Substance: Insulin Glulisine (rDNA origin)
    Pack: 1 box (5 x 3 mL pens 100 U/mL)

Select your currency
EUR Euro